english.prescrire.org > Spotlight > Archives : 2023 > Ustekinumab (Stelara°): no live vaccines before 6 months of age for infants who have been exposed in utero

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2023 : 1 | 30 | 60

Ustekinumab (Stelara°): no live vaccines before 6 months of age for infants who have been exposed in utero

 Adverse Effects  Infants exposed in utero to an immunosuppressant such as ustekinumab are, as a result, susceptible to serious infections for several months after birth if they are given a vaccine containing live attenuated bacteria or viruses.
Full article available for download by subscribers

©Prescrire 1 December 2023

Source: "Ustekinumab (Stelara°): no live vaccines before 6 months of age for infants who have been exposed in utero" Prescrire Int 2023; 32 (254): 299. Subscribers only.

Enjoy full access to Prescrire International, and support independent information
Share
Share on Facebook Share on Twitter


See also:
"Infliximab during pregnancy:
fatal BCG infections in infants"
Prescrire Int 2023;
 32 (244): 21.
Subscribers only


Read more:

This month's contents

All the subjects in
Prescrire's Spotlight